<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00443560</url>
  </required_header>
  <id_info>
    <org_study_id>0524-028</org_study_id>
    <nct_id>NCT00443560</nct_id>
  </id_info>
  <brief_title>The Association Between Decreasing Labor Analgesia Epidural Infusion and Forceps Delivery</brief_title>
  <official_title>A Retrospective Case-controlled Study of the Association Between Request to Discontinue Second Stage Labor Epidural Analgesia and Risk of Instrumental Vaginal Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study will be to compare epidural infusion management, specifically
      looking at infusion rate changes, in patients who receive forceps deliveries versus normal
      spontaneous vaginal deliveries. We will match patients based on time and date of delivery, as
      well as parity, in order to eliminate these variables as potential con-founders.

      We hypothesize patients who require a decrease in their basal labor analgesia epidural
      infusion rate will have an increased incidence of forceps delivery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The obstetrical anesthesia database will be queried for all forceps deliveries between the
      dates of January 2004-October 2005. To minimize the influence of different anesthetic and
      obstetric care providers, the control group consisted of parturients who has spontaneous
      vaginal deliveries (SVD) in the same 24 hour period who were case-matched for gravidity and
      parity. Parturients with twin deliveries and fetal demise were not selected for either group.

      The database will be queried for the following: maternal age, parity, gestational age, type
      of analgesia, changes in epidural infusion rate and/or concentration, and supplemental bolus
      doses of local anesthesia. The data will be stripped of identification by the database
      manager and entered into a secured computer which is password protected and maintained in the
      Department of Anesthesiology. The primary endpoint is to evaluate if decreasing the epidural
      infusion rate was associated with a forceps delivery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">March 2006</completion_date>
  <primary_completion_date type="Actual">March 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Parturients With a Decrease in the Infusion of Epidural Analgesia During Second Stage of Labor</measure>
    <time_frame>Second stage of labor up to 3 hours</time_frame>
    <description>At the request of the obstetric provider, second stage analgesia density was decreased by decreasing the basal infusion rate if there was dissatisfaction with the progress of labor or a perceived inability to push. The basal infusion was never totally discontinued.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Breakthrough Pain in the First Stage of Labor</measure>
    <time_frame>Supplemental analgesia in first stage of labor (&lt;24 hours)</time_frame>
    <description>Pain not responding to epidural analgesia in the first stage of labor was treated with bolus dose of bupivacaine 1.25 mg/mL or lidocaine 10 mg/mL, 10 to 15 mL. If pain relief was obtained the infusion concentration was increased. If the patient had no pain relief following the bolus injection, the epidural catheter was replaced.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Labor Analgesia</measure>
    <time_frame>Time form initiation of labor analgesia to delivery (up to 24 hours)</time_frame>
    <description>Time in minutes from initiation of labor analgesia until delivery of the infant</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2162</enrollment>
  <condition>Labor Pain</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Instrumental Vaginal Delivery (IVD)</arm_group_label>
    <description>Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spontaneous Vaginal Delivery (SVD)</arm_group_label>
    <description>The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Case controlled analysis of epidural labor analgesia patterns</intervention_name>
    <description>A retrospective study utilizing the Obstetric Anesthesiology Database to identify parturients who received neuraxial labor analgesia initiated with a combined spinal epidural (CSE) technique and maintained with a continuous epidural infusion with patient controlled epidural analgesia boluses</description>
    <arm_group_label>Instrumental Vaginal Delivery (IVD)</arm_group_label>
    <arm_group_label>Spontaneous Vaginal Delivery (SVD)</arm_group_label>
    <other_name>combined spinal epidural analgesia</other_name>
    <other_name>epidural labor analgesia</other_name>
    <other_name>bupivacaine</other_name>
    <other_name>fentanyl</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant Women
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singletons

          -  Viable fetal vaginal deliveries between January 2004-October 2005

        Exclusion Criteria:

          -  Outside specified time frame

          -  Multiparity

          -  Fetal demise
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cynthia A Wong, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Murphy DJ. Failure to progress in the second stage of labour. Curr Opin Obstet Gynecol. 2001 Dec;13(6):557-61. Review.</citation>
    <PMID>11707657</PMID>
  </reference>
  <reference>
    <citation>Comparative Obstetric Mobile Epidural Trial (COMET) Study Group UK. Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a randomised controlled trial. Lancet. 2001 Jul 7;358(9275):19-23.</citation>
    <PMID>11454372</PMID>
  </reference>
  <reference>
    <citation>Torvaldsen S, Roberts CL, Bell JC, Raynes-Greenow CH. Discontinuation of epidural analgesia late in labour for reducing the adverse delivery outcomes associated with epidural analgesia. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004457. Review.</citation>
    <PMID>15495111</PMID>
  </reference>
  <reference>
    <citation>Hess PE, Pratt SD, Soni AK, Sarna MC, Oriol NE. An association between severe labor pain and cesarean delivery. Anesth Analg. 2000 Apr;90(4):881-6.</citation>
    <PMID>10735793</PMID>
  </reference>
  <reference>
    <citation>Cohen SE, Yeh JY, Riley ET, Vogel TM. Walking with labor epidural analgesia: the impact of bupivacaine concentration and a lidocaine-epinephrine test dose. Anesthesiology. 2000 Feb;92(2):387-92.</citation>
    <PMID>10691224</PMID>
  </reference>
  <reference>
    <citation>Panni MK, Segal S. Local anesthetic requirements are greater in dystocia than in normal labor. Anesthesiology. 2003 Apr;98(4):957-63.</citation>
    <PMID>12657859</PMID>
  </reference>
  <reference>
    <citation>Yancey MK, Zhang J, Schweitzer DL, Schwarz J, Klebanoff MA. Epidural analgesia and fetal head malposition at vaginal delivery. Obstet Gynecol. 2001 Apr;97(4):608-12.</citation>
    <PMID>11275036</PMID>
  </reference>
  <reference>
    <citation>Wong CA, Scavone BM, Peaceman AM, McCarthy RJ, Sullivan JT, Diaz NT, Yaghmour E, Marcus RJ, Sherwani SS, Sproviero MT, Yilmaz M, Patel R, Robles C, Grouper S. The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. N Engl J Med. 2005 Feb 17;352(7):655-65.</citation>
    <PMID>15716559</PMID>
  </reference>
  <reference>
    <citation>9. Wong CA, Scavone BM, Sullivan JT, Ebarvia MJ, McCarthy RJ. The risk of cesarean delivery with early neuraxial analgesia in nulliparous induction of labor. http://www.asa-abstracts.com 2007:A1204.</citation>
  </reference>
  <reference>
    <citation>Ben-Haroush A, Melamed N, Kaplan B, Yogev Y. Predictors of failed operative vaginal delivery: a single-center experience. Am J Obstet Gynecol. 2007 Sep;197(3):308.e1-5.</citation>
    <PMID>17826432</PMID>
  </reference>
  <reference>
    <citation>Ziadeh S, Yahaya A. Pregnancy outcome at age 40 and older. Arch Gynecol Obstet. 2001 Mar;265(1):30-3.</citation>
    <PMID>11327090</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2007</study_first_submitted>
  <study_first_submitted_qc>March 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2007</study_first_posted>
  <results_first_submitted>May 9, 2011</results_first_submitted>
  <results_first_submitted_qc>June 22, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 21, 2011</results_first_posted>
  <last_update_submitted>March 17, 2014</last_update_submitted>
  <last_update_submitted_qc>March 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Cynthia Wong</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Labor</keyword>
  <keyword>Epidural Analgesia</keyword>
  <keyword>delivery</keyword>
  <keyword>vacuum extraction</keyword>
  <keyword>obstetrical Forceps</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The Obstetric Anesthesiology Database was used to identify parturients from the Labor and Delivery Unit of Prentice Women's Hospital of Northwestern Memorial Hospital who qualified for the study between January 2004 and October 2005.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Instrumental Vaginal Delivery (IVD)</title>
          <description>Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.</description>
        </group>
        <group group_id="P2">
          <title>Spontaneous Vaginal Delivery (SVD)</title>
          <description>The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1081"/>
                <participants group_id="P2" count="1081"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1021"/>
                <participants group_id="P2" count="1051"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>No intrathecal dose</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Multiple pregnancies or fetal demise</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Instrumental Vaginal Delivery (IVD)</title>
          <description>Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.</description>
        </group>
        <group group_id="B2">
          <title>Spontaneous Vaginal Delivery (SVD)</title>
          <description>The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1081"/>
            <count group_id="B2" value="1081"/>
            <count group_id="B3" value="2162"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1081"/>
                    <measurement group_id="B2" value="1081"/>
                    <measurement group_id="B3" value="2162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32" spread="3"/>
                    <measurement group_id="B2" value="31" spread="3"/>
                    <measurement group_id="B3" value="31" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1081"/>
                    <measurement group_id="B2" value="1081"/>
                    <measurement group_id="B3" value="2162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1081"/>
                    <measurement group_id="B2" value="1081"/>
                    <measurement group_id="B3" value="2162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Parturients With a Decrease in the Infusion of Epidural Analgesia During Second Stage of Labor</title>
        <description>At the request of the obstetric provider, second stage analgesia density was decreased by decreasing the basal infusion rate if there was dissatisfaction with the progress of labor or a perceived inability to push. The basal infusion was never totally discontinued.</description>
        <time_frame>Second stage of labor up to 3 hours</time_frame>
        <population>Analysis was per protocal</population>
        <group_list>
          <group group_id="O1">
            <title>Instrumental Vaginal Delivery (IVD)</title>
            <description>Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.</description>
          </group>
          <group group_id="O2">
            <title>Spontaneous Vaginal Delivery (SVD)</title>
            <description>The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Parturients With a Decrease in the Infusion of Epidural Analgesia During Second Stage of Labor</title>
          <description>At the request of the obstetric provider, second stage analgesia density was decreased by decreasing the basal infusion rate if there was dissatisfaction with the progress of labor or a perceived inability to push. The basal infusion was never totally discontinued.</description>
          <population>Analysis was per protocal</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1021"/>
                <count group_id="O2" value="1051"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146"/>
                    <measurement group_id="O2" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>Chi-squared, Corrected</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>2.3</ci_lower_limit>
            <ci_upper_limit>4.5</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Breakthrough Pain in the First Stage of Labor</title>
        <description>Pain not responding to epidural analgesia in the first stage of labor was treated with bolus dose of bupivacaine 1.25 mg/mL or lidocaine 10 mg/mL, 10 to 15 mL. If pain relief was obtained the infusion concentration was increased. If the patient had no pain relief following the bolus injection, the epidural catheter was replaced.</description>
        <time_frame>Supplemental analgesia in first stage of labor (&lt;24 hours)</time_frame>
        <population>Analysis was per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Instrumental Vaginal Delivery (IVD)</title>
            <description>Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.</description>
          </group>
          <group group_id="O2">
            <title>Spontaneous Vaginal Delivery (SVD)</title>
            <description>The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Breakthrough Pain in the First Stage of Labor</title>
          <description>Pain not responding to epidural analgesia in the first stage of labor was treated with bolus dose of bupivacaine 1.25 mg/mL or lidocaine 10 mg/mL, 10 to 15 mL. If pain relief was obtained the infusion concentration was increased. If the patient had no pain relief following the bolus injection, the epidural catheter was replaced.</description>
          <population>Analysis was per protocol</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1021"/>
                <count group_id="O2" value="1051"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Supplemental bolus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="802"/>
                    <measurement group_id="O2" value="243"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infusion increase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="149"/>
                    <measurement group_id="O2" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Concentration increase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>Chi-squared, Corrected</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>12.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>9.9</ci_lower_limit>
            <ci_upper_limit>15.0</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Labor Analgesia</title>
        <description>Time in minutes from initiation of labor analgesia until delivery of the infant</description>
        <time_frame>Time form initiation of labor analgesia to delivery (up to 24 hours)</time_frame>
        <population>Analysis was per protocal</population>
        <group_list>
          <group group_id="O1">
            <title>Instrumental Vaginal Delivery (IVD)</title>
            <description>Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.</description>
          </group>
          <group group_id="O2">
            <title>Spontaneous Vaginal Delivery (SVD)</title>
            <description>The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Labor Analgesia</title>
          <description>Time in minutes from initiation of labor analgesia until delivery of the infant</description>
          <population>Analysis was per protocal</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1021"/>
                <count group_id="O2" value="1051"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="420" lower_limit="300" upper_limit="570"/>
                    <measurement group_id="O2" value="300" lower_limit="210" upper_limit="420"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Adverse events were not extracted from charts reviewed in this study</desc>
      <group_list>
        <group group_id="E1">
          <title>Instrumental Vaginal Delivery (IVD)</title>
          <description>Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.</description>
        </group>
        <group group_id="E2">
          <title>Spontaneous Vaginal Delivery (SVD)</title>
          <description>The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The retrospective design incurs the risk of unrecorded or unobserved data. The sample selected included all patients with neuraxial analgesia who underwent IVD, but a limited sample of SVD.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Robert J. McCarthy, PharmD</name_or_title>
      <organization>Northwestern University Feinberg School of Medicine</organization>
      <phone>312-926-9015</phone>
      <email>r-mccarthy@northwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

